Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

Giovanni Fucà,Giulia Galli,M. Poggi,Giuseppe Lo Russo,Claudia Proto,Martina Imbimbo,Milena Vitali,Monica Ganzinelli,Claudia Lanti,Giuliano Molino,Fabiano Stangoni,Nicoletta Zilembo,Filippo de Braud,Marina Chiara Garassino,Diego Signorelli

Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

2018

Giovanni Fucà
Giulia Galli
M. Poggi
Giuseppe Lo Russo
Claudia Proto
Martina Imbimbo
Milena Vitali
Monica Ganzinelli
Claudia Lanti
Giuliano Molino
Fabiano Stangoni
Nicoletta Zilembo
Filippo de Braud
Marina Chiara Garassino
Diego Signorelli

Background A consistent percentage of patients with metastatic non-small cell lung cancer (NSCLC) derives no or only marginal benefit from immunotherapy (IO).

Keywords:

Immunology
Immunotherapy
Lung cancer
Cancer research
Medicine
Gastroenterology
Cohort
Sodium
Internal medicine
Cohort study
Carcinoma
Pharmacology
low sodium
Progression-free survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations